Biocare Medical, a Pacheco, California-based provider of immunohistochemistry instrumentation, as well as a full range of reagents for IHC and molecular testing, received an investment from Excellere Partners.
The amount of the deal was not disclosed.
The investment will help the company enhance and accelerate growth opportunities.
Led by Roy Paxton Yih, co-founder and Chief Executive Officer, Biocare provides IHC and molecular diagnostic reagents, including simultaneous Multiplex IHC tests at diagnostic decision points. The company’s customers include clinical and hospital laboratories, pharmaceutical companies, and biotechnology companies as well as academic, government, military, and other nonprofit laboratories.